Harbour BioMed Lands $85M In Series B Funding
Harbour BioMed has completed a Series B-1 funding round that added $85 million to continue the company's development of therapeutic gene-targeting technologies for cancer and expand its global footprint, bringing its...To view the full article, register now.
Already a subscriber? Click here to view full article